ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,668Medicare Part D Prescriptions Filled, Including Refills

Rank: 219 out of 1185

$450K Total Retail Price of All Prescriptions

Rank: 324 out of 1185

591 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 591 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 591 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 5,708 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
SIMVASTATIN 665 466 1 5
HYDROCODONE-ACETAMINOPHEN 511 234 S3 2 2
OMEPRAZOLE 334 165 3 6
LISINOPRIL 314 181 4 4
LEVOTHYROXINE SODIUM 306 217 5 3
METFORMIN HCL 278 186 6 9
TRAMADOL HCL 246 134 7 16
CIPROFLOXACIN HCL 220 143 8 62
FUROSEMIDE 213 142 9 8
ATORVASTATIN CALCIUM 194 143 10 11
SERTRALINE HCL 188 87 11 25
AMLODIPINE BESYLATE 178 152 12 1
METOPROLOL SUCCINATE 145 97 13 20
METOPROLOL TARTRATE 133 77 14 10
GABAPENTIN 130 32 15 13
ZOLPIDEM TARTRATE 128 72 16 15
LOSARTAN POTASSIUM 124 93 17 26
NEXIUM 124 51 17 19
WARFARIN SODIUM 109 98 19 21
CRESTOR 98 60 20 23
JANUVIA 91 60 21 68
FENOFIBRATE 89 61 22 55
PRAVASTATIN SODIUM 87 46 23 7
HYDROCHLOROTHIAZIDE 83 50 24 12
PROAIR HFA 77 30 25 50
CYCLOBENZAPRINE HCL 73 0 R 26 53
ALLOPURINOL 73 45 26 30
PROPRANOLOL HCL 72 57 28 163
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 52 28 14
AZITHROMYCIN 71 41 30 39
GLIPIZIDE ER 65 55 31 77
VERAPAMIL ER 62 49 32 98
FLUOXETINE HCL 59 0 33 52
CELEBREX 59 39 33 85
ACTOS 56 43 35 86
AMOXICILLIN 55 31 36 99
GLIPIZIDE 55 29 36 56
POTASSIUM CHLORIDE 54 24 38 18
PAROXETINE HCL 53 29 39 73
NABUMETONE 53 32 39 165
ENALAPRIL MALEATE 52 39 41 65
ROPINIROLE HCL 52 34 41 108
ALENDRONATE SODIUM 52 51 41 40
ATENOLOL 52 44 41 28
ESCITALOPRAM OXALATE 51 36 45 79
CLONIDINE HCL 50 34 46 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 31, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.